sufficiently free of protein. Final concentration of the ct-DNA stock solution was measured spectrophotometrically using extinction coefficient of 6600 cm -1 mol -1 dm -3 [16] . Tris-HCl buffer was filtered through a 0.45 μm Millipore Millex-HV PVDF filter and pH was measured by using Mettler-Toledo pH meter (model S20).
General procedure for binding measurements
UV-Visible spectra in the range of 220 to 340 nm were recorded on Perkin-Elmer Lambda 45 Spectrophotometer equipped with autosampler and water-bath with temperature controller. Quartz cuvettes of 1 cm path length were used for the measurements. Increasing concentration of procaine was titrated against 30 x10 -6 mol dm -3 of ct-DNA. A fixed amount of procaine (0-35 x10 -6 mol dm -3 ) was taken in the blank and baseline was corrected before each measurement. Therefore, the obtained spectra could be considered as difference spectra.
Fluorescence measurements were performed on Hitachi spectrofluorometer (Model F 7000) equipped with a PC and programmable temperature controller. The fluorescence spectra were collected at 15, 25 and 35 °C with a fluorescence cell of path length 1 cm. The excitation and emission slits were set at 10 nm. Though, ct-DNA displays very small absorbance at the excitation and emission wavelengths of procaine (290 nm and 355 nm, respectively), inner filter effect was corrected for the fluorescence data used for calculations of quenching, binding and thermodynamic parameters by using following equation:
where, F corr and F obs are the corrected and observed fluorescence emission intensities, respectively, A exi and A emi are the absorbance at the excitation and emission wavelengths, respectively.
The competitive interactions between fluorescence probes (EtBr and DAPI) and procaine with ct-DNA were performed by successively adding an appropriate amount of procaine solution to the quartz cuvette containing a fixed concentration of EtBr-ct-DNA or DAPI-ct-DNA complex solution. The concentrations of EtBr, DAPI and ct-DNA were kept at 80.0 x10 -6 mol dm -3 , 12.5 x10 -6 mol dm -3 , and 10.0 x10 -6 mol dm -3 , respectively [1] . After these solutions were mixed sufficiently and stood for 5 min, the fluorescence emission spectra were recorded with excitation wavelengths at 480 nm and 341 nm, respectively.
DNA melting study was performed in absence and presence procaine by monitoring the absorbance intensity at 260 nm over a wide range of temperature ranging from 25-100 °C. ct-DNA (30 x10 -6 mol dm -3 ) was taken alone or in presence of 30 x10 -6 mol dm -3 The viscosity of the DNA solution was measured at 25 °C. a 50 mL solution of 30 x10 -6 mol dm -3 ct-DNA was transferred to the Ostwald viscometer and the flow time was measured.
Then, the solutions containing the mixtures of ct-DNA and procaine in various ratios were checked for the flow time. Each point measured was the average of at least three readings. The data were presented as the relative specific viscosity (η/η 0 ) 1/3 versus r i , η is the specific viscosity of ct-DNA in the presence of the procaine and η 0 is the specific viscosity of ct-DNA alone.
Computational studies
The geometries of procaine and DNA bases were optimized at DFT/ BP RI by ORCA [2] . Autodock 4.2.3 Program was used to perform docking calculations of DNA with procaine [3] . Five different conformer of DNA were taken from RSCB protein databank and the structure of procaine was obtained from pubchem. In the blind docking calculations, a grid box of 90×90×90 Å with spacing of 0.357 Å was used to enclose DNA and procaine. The Lamarckian Genetic Algorithm method was used as the searching algorithm. Then the GA population size, the maximum number of energy evaluation, and the number of GA runs were set at 150, 2,500,000, and 100, respectively. The other AutoDock parameters were set to default. In addition, discovery studio visualizer software [4] and pymol [5] were used to analyse the predicated binding mode.
General procedure for anticancer activities

Cell culture and treatments
The MCF-7 human breast adenocarcinoma cell line was obtained from American Type Culture Collection (ATCC, Rockville, MD, USA). The cells were maintained in MEM with 15% FBS and 1% penicillin/ streptomycin in a completely humidified atmosphere with 95% air and 5% CO 2 at 37 o C. Cells were grown as adherent monolayers in T-25 and T-75 culture flasks. The exponentially growing cells at 90-95% confluence were harvested using 0.25% trypsin/ EDTA solution and sub-cultured into 6-well or 96-well plates according to the experimental requirements. The viability of the cells was determined by staining with trypan blue. The cells were counted using a cell counter (Bio Rad TC20 automated cell counter) and diluted in medium at a density of 1 × 10 5 cells/ ml to be used throughout the experiments. A stock solution of procaine and doxorubicin was prepared in Millipore water (w/v) and was then diluted in cell culture medium to obtain the desired concentrations for cell treatment.
Cytotoxicity assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay [36] with modification was used to analyze the cytotoxic activity procaine. A CellTitre 96 ® non-radioactive cell proliferations assay kit (Promega, Madison, WI, USA) was used following the manufacturer's instructions. Briefly, the MCF-7 cells (1 × 10 4 cells/ well) were grown overnight in 96-well flat bottom cell culture plates, and were then exposed to six different concentrations of two-fold dilutions of 50 x10 -6 mol dm -3 procaine and doxorubicin (50, 25, 12.5, 6.25, 3.12 and 1.56 x10 -6 mol dm -3 ) for 24 hrs. A negative control (untreated) was also maintained for comparison. In addition, another group of experiment was setup for combination treatment using two-fold dilution of procaine (50 x10 -6 mol dm -3 ) supplemented with 5 x10 -6 mol dm -3 doxorubicin for same duration. After the completion of the desired treatment, 15 µl of MTT reagent, provided in the kit, was added to each well and further incubated for 3 hrs at 37 °C. Finally, the medium with MTT solution was removed, and 200 µl of solubilization solution was added to each well and further incubated for 30 min by occasional vortexing. The optical density (OD) of each well was measured at 550 nm by using a Synergy microplate reader (BioTek, Winooski, VA, USA). Results were generated from three independent experiments and each experiment was performed in triplicate. The percentage of cytotoxicity compared to the untreated cells was estimated in order to determine the IC 50 value (the concentration at which 50% cell proliferation is inhibited).
Morphological changes analysis
Cells were seeded in a 6-well plate at a density of 1 × 10 5 cells per well and allowed to grow overnight. Morphological changes were observed to determine the alterations induced by procaine and doxorubicin alone or in combination in MCF-7 cells treated with 5 x10 -6 mol dm -3 for 24 hrs. After the end of the incubation period, cells were washed with PBS (pH-7.4) and observed under a phase contrast inverted microscope equipped with a digital camera (Olympus IX51, Tokyo, Japan) at 100× magnification.
Apoptotic morphological changes by acridine orange-ethidium bromide dual staining method
Acridine orange and Ethidium bromide dual staining method was adopted to differentiate between condensed apoptotic or necrotic nuclei from normal cells. Cells were seeded on a coverslip-loaded 6-well plate at a density of 1 × 10 5 cells per well and allowed to grow overnight.
Then the cells were exposed to 5 x10 -6 mol dm -3 procaine and doxorubicin alone or in combination for 24 hrs. After end of treatment, cells were washed twice using PBS to remove the remaining media. Then, cells were stained by adding equal volumes of AO and PI (20 μg/mL in PBS). Finally, after washing with PBS, the stained cells were mounted onto a microscope slide in mounting medium and images were collected using appropriate filter settings in a compound microscope (Olympus BX41, Japan) fitted with fluorescence attachment and CCD camera.
Quantification of apoptotic and necrotic cells based on the uptake of acridine orange and propidium iodide in more than 300 cells was performed. The criteria for identification were as follows: green intact nucleus, viable cells; dense green areas of chromatin condensation in the nucleus, apoptosis; orange intact nucleus, necrosis.
Annexin V-FITC apoptosis assay
Apoptosis was measured using fluorescence microscopy by analyzing the translocation of phosphatidylserine on the outer membrane of apoptotic cells. An annexin-V FITC apoptosis detection Kit was used for the differentiation of early apoptotic, late apoptotic and necrotic cells.
Briefly, MCF-7 cells were grown and exposed to the test compounds on a cover-slip-loaded 6-well plate at a density of 1 × 10 5 cells per well as mentioned above. After end of treatment, cells were washed twice using PBS to remove the remaining media. Then cells were stained with 5 µl each of annexin V-FITC and PI for 20 min at room temperature in dark. Finally, after washing with PBS, the stained cells were mounted onto a microscope slide in mounting medium and images were collected using appropriate filter settings in a compound microscope (Olympus BX41, Japan) fitted with fluorescence attachment and CCD camera.
Statistical analysis
All experiments were carried out with three independent replicates and values are presented as mean ± standard error of mean (SEM). Data were statistically analyzed using the Student's ttest for comparison between the means applying a significance level of P < 0.05. 
